Increasing trends of anaphylaxis-related events: an analysis of anaphylaxis using nationwide data in Taiwan, 2001-2013

被引:24
|
作者
Yao, Tsung-Chieh [1 ,2 ,3 ,4 ]
Wu, Ann Chen [5 ,6 ,7 ]
Huang, Ya-Wen [8 ]
Wang, Jiu-Yao [9 ,10 ]
Tsai, Hui-Ju [8 ]
机构
[1] Chang Gung Mem Hosp, Dept Pediat, Div Allergy Asthma & Rheumatol, Taoyuan, Taiwan
[2] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
[3] Chang Gung Mem Hosp, Chang Gung Immunol Consortium, Taoyuan, Taiwan
[4] Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan
[5] Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Precis Med & Translat Res PROMoTeR Ctr, Boston, MA USA
[6] Harvard Med Sch, Boston, MA USA
[7] Childrens Hosp, Dept Pediat, 300 Longwood Ave, Boston, MA 02115 USA
[8] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Miaoli 350, Taiwan
[9] Natl Cheng Kung Univ, Coll Med, Dept Pediat, Tainan, Taiwan
[10] Natl Cheng Kung Univ, Allergy & Clin Immunol Res ACIR Ctr, Tainan, Taiwan
来源
关键词
Anaphylaxis; Epidemiology; Incidence; Time trends; Asian; FOOD ALLERGY; EPIDEMIOLOGY; CHILDREN; SHOCK; RISK; HOSPITALIZATIONS; PREVALENCE; ADMISSIONS; GENDER; SEX;
D O I
10.1186/s40413-018-0202-7
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
BackgroundAnaphylaxis is a severe, potentially fatal, and systemic allergic reaction. Previous studies document increasing trends in incidence rates of anaphylaxis-related events in Western countries, yet little is known about the incidence and trend of anaphylaxis in Asia. In this study, we aimed to determine time trends in incidence rates of anaphylaxis-related events in Taiwan from 2001 through 2013.MethodsWe utilized medical claims data from the National Health Insurance Research Databases in Taiwan. We identified anaphylaxis-related events (ICD-9-CM-codes: 995.0, 995.60-995.69, 999.41-999.42, and 999.49) and calculated incidence rates. Poisson regression models were applied to examine trends and incidence rates.ResultsA total of 2496 patients (mean age, 45.11years; 56% male) with first-time anaphylaxis were identified during 34,430,000 person-years of observation time. The overall incidence of anaphylaxis was 7.25 (95% confidence interval (CI)=6.97-7.53) per 100,000 person-years, increasing from 4.79 in 2001 to 8.20 in 2013, with an incidence rate ratio (IRR) of 1.05 (95%CI=1.04-1.06). Over the 13-year period, the increasing trends were found in incident diagnosis of anaphylaxis-related outpatient or emergency department visits (IRR=1.06, 95%CI=1.05-1.08) and admissions to intensive care units (IRR=1.06, 95%CI=1.03-1.10), whereas the trends in incidence of anaphylaxis-related hospitalizations remained steady. The proportion of patients requiring hospitalizations among all patients with anaphylaxis (p(_trend)=0.01), as well as the proportion requiring intensive care treatment among patients who were hospitalized (p(_trend)=0.01), both increased with age.ConclusionThe incidence rate of anaphylaxis in Taiwanhas increased at an average rate of 5% annually since 2001, paralleling the rising trends in several Western countries.
引用
收藏
页数:8
相关论文
共 15 条
  • [1] Increasing trends of anaphylaxis-related events: An analysis of anaphylaxis nationwide data in Taiwan, 2001-2013
    Yao, Tsung-Chieh
    Huang, Ya-Wen
    Wu, Hsiao-Ting
    Tsai, Yu-Ting
    Wang, Jiu-Yao
    Tsai, Hui-Ju
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB153 - AB153
  • [2] Increase in anaphylaxis-related hospitalizations but no increase in fatalities: An analysis of United Kingdom national anaphylaxis data, 1992-2012
    Turner, Paul J.
    Gowland, M. Hazel
    Sharma, Vibha
    Ierodiakonou, Despo
    Harper, Nigel
    Garcez, Tomaz
    Pumphrey, Richard
    Boyle, Robert J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (04) : 956 - +
  • [3] Increasing Trends in the Nationwide Incidence of Anaphylaxis Visiting Emergency Room in Korea from 2007 to 2013
    Ahn, Young Min
    Chung, Eun-Hee
    Won, Youn Kyung
    Chung, Yoo Mi
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB54 - AB54
  • [4] Trend and Characteristics of Anaphylaxis-related Hospitalization From 2009-2011: Data from the Nationwide Inpatient Sample
    Shrestha, Pragya
    Dhital, Rashmi
    Poudel, Dilli
    Karmacharya, Paras
    Donato, Anthony
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB36 - AB36
  • [5] Anaphylaxis-related mortality in the obstetrical setting: analysis of the French National Confidential Enquiry into Maternal Deaths from 2001 to 2012
    Tacquard, Charles
    Chassard, Dominique
    Malinovsky, Jean-Marc
    Saucedo, Monica
    Deneux-Tharaux, Catherine
    Mertes, Paul Michel
    BRITISH JOURNAL OF ANAESTHESIA, 2019, 123 (01) : E151 - E153
  • [6] Time trends in incidence rates of atrial fibrillation-related strokes in Norway 2001-2014: a nationwide analysis using data from the cardiovascular disease in Norway (CVDNOR) project
    Ariansen, I
    Igland, J.
    Anjum, M.
    Kjerpeseth, L. J.
    Selmer, R.
    Ellekjaer, H.
    Kalstoe, S.
    Christophersen, I
    Myrstad, M.
    Ihle-Hansen, H.
    Tveit, A.
    Mortensen, L. H.
    Tell, G. S.
    Berge, T.
    EUROPEAN HEART JOURNAL, 2020, 41 : 523 - 523
  • [7] Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System
    Henry Trumbo
    Karolina Kaluza
    Syed Numan
    Lawrence T. Goodnough
    Drug Safety, 2021, 44 : 107 - 119
  • [8] Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System
    Trumbo, Henry
    Kaluza, Karolina
    Numan, Syed
    Goodnough, Lawrence T.
    DRUG SAFETY, 2021, 44 (01) : 107 - 119
  • [9] Comment on: Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System
    Auerbach, Michael
    DRUG SAFETY, 2021, 44 (05) : 609 - 610